ClinConnect ClinConnect Logo
Search / Trial NCT06379529

The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events

Launched by NUVOAIR MEDICAL PC · Apr 18, 2024

Trial Information

Current as of July 24, 2025

Not yet recruiting

Keywords

Copd Copd Exacerbation Copd Hospitalization Copd Readmission Copd Costs Medicare Medicare Advantage

ClinConnect Summary

The COPD CARE Study is looking at how a virtual healthcare service, called NuvoAir, can help people with Chronic Obstructive Pulmonary Disease (COPD). The goal is to see if this new approach can lead to fewer serious COPD flare-ups and heart problems, while also reducing the number of doctor's visits and overall healthcare costs compared to traditional care. This study will involve up to 1,050 participants over a year and is designed to help improve the quality of care for individuals living with COPD.

To be eligible for this study, participants need to have been diagnosed with COPD and experienced a serious flare-up in the past year that required an emergency room visit or hospitalization. They should also be able to understand and follow instructions, have access to a phone, and be willing to share their health information with doctors involved in the study. Participants can expect to engage with the virtual service, which may include remote check-ins and support from healthcare providers, all from the comfort of their own home. This study is currently not recruiting participants, but it aims to provide valuable insights into new ways to manage COPD effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Twelve months of claims data in the health insurer or provider's database for baseline
  • ICD10 code for COPD (including emphysema and chronic bronchitis) with a severe exacerbation of COPD in the previous 12 months (defined as ER visit or hospitalization related to COPD or severity score of 2 or 3)
  • Cooperative, i.e., subject should be able to follow and understand instructions
  • Access to a phone (smartphone, cell phone, or landline)
  • Willingness to sign a medical release form for treating healthcare facilities
  • Exclusion Criteria:
  • Does not have access to a a phone (smartphone, cell phone, or landline)
  • Lack of cooperation, subject cannot follow and understand instructions
  • Other serious medical illness that, in the opinion of the PI, would interfere with the patient's participation in the study or interpretation of their data (i.e., terminal illness, unstable psychiatric condition, etc.)
  • Does not understand English

About Nuvoair Medical Pc

NuvoAir Medical PC is a pioneering clinical trial sponsor dedicated to advancing respiratory health through innovative research and development. With a strong focus on leveraging cutting-edge technology and patient-centered approaches, NuvoAir aims to enhance treatment options for individuals with chronic respiratory conditions. The organization collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials that drive evidence-based practices and improve patient outcomes. Committed to excellence and integrity, NuvoAir plays a vital role in transforming the landscape of respiratory medicine.

Locations

Patients applied

0 patients applied

Trial Officials

Ken Cohen, MD

Principal Investigator

Executive Director of Translational Research, OptumCare

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported